Bioavailability Challenge

(Image: Getty/Wavebreakmedia)

Q&A

Nemaura to debut 48-hour transdermal pain patch

By Ben Hargreaves

Ahead of the CPhI Worldwide in Madrid next week, Nemaura announced that it would be showcasing its newly developed 48-hour diclofenac transdermal patch and would be linking up with an unnamed global pharma company to develop three new products.

(Image: Getty/Magicmine)

Insmed gets US approval for inhaled antibiotic

By Ben Hargreaves

Insmed has become the first company to receive approval through the limited population pathway for antibacterial and antifungal drugs set up by the US FDA in 2016.

Getty/Ninitta

Significant step taken towards insulin pill

By Ben Hargreaves

Researchers from Harvard University have developed an insulin formulation using two ionic liquids they say could lead to the development of a pill for diabetics.